These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 14519077)

  • 1. Antibodies as therapeutic agents: vive la renaissance!
    Stockwin LH; Holmes S
    Expert Opin Biol Ther; 2003 Oct; 3(7):1133-52. PubMed ID: 14519077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of therapeutic antibodies in drug discovery.
    Stockwin LH; Holmes S
    Biochem Soc Trans; 2003 Apr; 31(2):433-6. PubMed ID: 12653655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered antibody fragments and the rise of single domains.
    Holliger P; Hudson PJ
    Nat Biotechnol; 2005 Sep; 23(9):1126-36. PubMed ID: 16151406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-chain antibodies as new antithrombotic drugs.
    Hagemeyer CE; Schwarz M; Peter K
    Semin Thromb Hemost; 2007 Mar; 33(2):185-95. PubMed ID: 17340468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of nanobodies for therapeutic applications.
    Van Bockstaele F; Holz JB; Revets H
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1212-24. PubMed ID: 19876789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody engineering at the millennium.
    Gavilondo JV; Larrick JW
    Biotechniques; 2000 Jul; 29(1):128-32, 134-6, 138 passim. PubMed ID: 10907088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment.
    Iezzi ME; Policastro L; Werbajh S; Podhajcer O; Canziani GA
    Front Immunol; 2018; 9():273. PubMed ID: 29520274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant antibodies: a novel approach to cancer diagnosis and therapy.
    Hudson PJ
    Expert Opin Investig Drugs; 2000 Jun; 9(6):1231-42. PubMed ID: 11060739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Antibody Fragments for Neurological Disorders: An Update.
    Manoutcharian K; Gevorkian G
    Curr Neuropharmacol; 2024; 22(13):2157-2167. PubMed ID: 37646225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-chain antibodies in pancreatic cancer.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Batra SK
    Ann N Y Acad Sci; 1999 Jun; 880():263-80. PubMed ID: 10415872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody Engineering & Design 2010. 24-25 February 2010, Frankfurt, Germany.
    Beck A
    IDrugs; 2010 May; 13(5):295-9. PubMed ID: 20432182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designer genes: recombinant antibody fragments for biological imaging.
    Wu AM; Yazaki PJ
    Q J Nucl Med; 2000 Sep; 44(3):268-83. PubMed ID: 11105590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies and their fragments as anti-cancer agents.
    Schaedel O; Reiter Y
    Curr Pharm Des; 2006; 12(3):363-78. PubMed ID: 16454750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of therapeutic monoclonal antibodies: promises and pitfalls of in vitro and in vivo assays.
    Golay J; Introna M
    Arch Biochem Biophys; 2012 Oct; 526(2):146-53. PubMed ID: 22387378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailor-made antibody therapeutics.
    Chowdhury PS; Wu H
    Methods; 2005 May; 36(1):11-24. PubMed ID: 15848071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview on the use of therapeutic antibodies in drug discovery.
    Roguska M; Kaymakcalan Z; Salfeld J
    Curr Protoc Pharmacol; 2005 Jan; Chapter 9():Unit 9.7. PubMed ID: 22294129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant antibodies for cancer diagnosis and therapy.
    Souriau C; Hudson PJ
    Expert Opin Biol Ther; 2003 Apr; 3(2):305-18. PubMed ID: 12662144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibody alternative formats: antibody fragments and new frameworks].
    Kitten O; Martineau P
    Med Sci (Paris); 2019 Dec; 35(12):1092-1097. PubMed ID: 31903922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.